What do systematic reviews say?

Radially expanding trocars vs cutting trocars

It is very uncertain whether radially expanding trocars changes trocar site bleeding compared with cutting trocars (very low certainty).

• Trocar types in laparoscopy 2015 · Cochrane Headline outcomes only
  OR 0.28 [0.14, 0.54]
  5 studies · 553 participants
  Very low

Radially expanding trocars vs cutting trocars

• Trocar types in laparoscopy 2015 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 238 participants
  Very low

Radially expanding trocars vs cutting trocars

• Trocar types in laparoscopy 2015 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 306 participants
  GRADE not reported

Conical blunt‐tipped trocar vs cutting trocars

• Trocar types in laparoscopy 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 42 participants
  Very low

Conical blunt‐tipped trocar vs cutting trocars

• Trocar types in laparoscopy 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 42 participants
  Very low

Conical blunt‐tipped trocar vs cutting trocars

It is very uncertain whether conical blunt‐tipped trocar changes trocar site bleeding compared with cutting trocar (very low certainty).

• Trocar types in laparoscopy 2015 · Cochrane Headline outcomes only
  OR 0.13 [0.01, 2.12]
  1 study · 30 participants
  Very low

GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GnRH‐a + tibolone vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GnRH‐a + tibolone vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 268 participants
  GRADE not reported

GnRH‐a + tibolone vs GnRH‐a ± placebo

GnRH‐a + tibolone showed no clear difference in rate of vasomotor symptoms ‐ compared with gnRH‐a ± placebo (low certainty).

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  RR 0.38 [0.14, 1.02]
  1 study · 20 participants
  Low

GnRH‐a + raloxifene vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 74 participants
  Low

GnRH‐a + raloxifene vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 91 participants
  Low

GnRH‐a + raloxifene vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 91 participants
  Low

GnRH‐a + raloxifene vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 91 participants
  Low

GnRH‐a + raloxifene vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 91 participants
  Low

GnRH‐a + raloxifene vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GnRH‐a + estriol vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 16 participants
  Low

GnRH‐a + estriol vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 12 participants
  Low

GnRH‐a + estriol vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found